메뉴 건너뛰기




Volumn 15, Issue 4, 2014, Pages 129-136

Spatial mapping of functional pelvic bone marrow using FLT PET

Author keywords

Bone marrow; FLT PET; Pelvic cancer

Indexed keywords


EID: 84906088386     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v15i4.4780     Document Type: Article
Times cited : (31)

References (25)
  • 1
    • 0000259332 scopus 로고
    • The distribution of active bone marrow in the adult
    • Ellis RE. The distribution of active bone marrow in the adult. Phys Med Biol. 1961;5:255-58.
    • (1961) Phys Med Biol , vol.5 , pp. 255-258
    • Ellis, R.E.1
  • 2
    • 0028903635 scopus 로고
    • Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy
    • Mauch P, Constine L, Greenberger J, et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31(5):1319-39.
    • (1995) Int J Radiat Oncol Biol Phys , vol.31 , Issue.5 , pp. 1319-1339
    • Mauch, P.1    Constine, L.2    Greenberger, J.3
  • 3
    • 0035064625 scopus 로고    scopus 로고
    • Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer
    • Abu-Rustum NR, Lee S, Correa A, Massad LS. Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer. Gynecol Oncol. 2001;81(1):88-91.
    • (2001) Gynecol Oncol , vol.81 , Issue.1 , pp. 88-91
    • Abu-Rustum, N.R.1    Lee, S.2    Correa, A.3    Massad, L.S.4
  • 4
    • 78149360386 scopus 로고    scopus 로고
    • Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: preliminary results of a multicentre phase II trial
    • Bolla M, Hannoun-Levi JM, Ferrero JM, et al. Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: preliminary results of a multicentre phase II trial. Radiother Oncol. 2010;97(2):312-17.
    • (2010) Radiother Oncol , vol.97 , Issue.2 , pp. 312-317
    • Bolla, M.1    Hannoun-Levi, J.M.2    Ferrero, J.M.3
  • 5
    • 0036890734 scopus 로고    scopus 로고
    • Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies
    • Brixey CJ, Roeske JC, Lujan AE, Yamada SD, Rotmensch J, Mundt AJ. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002;54(5):1388-96.
    • (2002) Int J Radiat Oncol Biol Phys , vol.54 , Issue.5 , pp. 1388-1396
    • Brixey, C.J.1    Roeske, J.C.2    Lujan, A.E.3    Yamada, S.D.4    Rotmensch, J.5    Mundt, A.J.6
  • 6
    • 83955163008 scopus 로고    scopus 로고
    • Neoadjuvant bevacizumab, oxaliplatin, 5-fluorouracil, and radiation for rectal cancer
    • Dipetrillo T, Pricolo V, Lagares-Garcia J, et al. Neoadjuvant bevacizumab, oxaliplatin, 5-fluorouracil, and radiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2012;82(1):124-29.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , Issue.1 , pp. 124-129
    • Dipetrillo, T.1    Pricolo, V.2    Lagares-Garcia, J.3
  • 7
    • 9544252934 scopus 로고    scopus 로고
    • Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study
    • Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14(9):2527-39.
    • (1996) J Clin Oncol , vol.14 , Issue.9 , pp. 2527-2539
    • Flam, M.1    John, M.2    Pajak, T.F.3
  • 8
    • 0033561259 scopus 로고    scopus 로고
    • Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
    • Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(15):1154-61.
    • (1999) N Engl J Med , vol.340 , Issue.15 , pp. 1154-1161
    • Keys, H.M.1    Bundy, B.N.2    Stehman, F.B.3
  • 9
    • 0033561333 scopus 로고    scopus 로고
    • Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
    • Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144-53.
    • (1999) N Engl J Med , vol.340 , Issue.15 , pp. 1144-1153
    • Rose, P.G.1    Bundy, B.N.2    Watkins, E.B.3
  • 10
    • 79955953373 scopus 로고    scopus 로고
    • Review of chemoradiotherapy for high-risk prostate cancer
    • Sanfilippo N, Hardee ME, Wallach J. Review of chemoradiotherapy for high-risk prostate cancer. Rev Recent Clin Trials. 2011;6(1):64-68.
    • (2011) Rev Recent Clin Trials , vol.6 , Issue.1 , pp. 64-68
    • Sanfilippo, N.1    Hardee, M.E.2    Wallach, J.3
  • 11
    • 75749110904 scopus 로고    scopus 로고
    • Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors
    • Nugent EK, Case AS, Hoff JT, et al. Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. Gynecol Oncol. 2010;116(3):438-41
    • (2010) Gynecol Oncol , vol.116 , Issue.3 , pp. 438-441
    • Nugent, E.K.1    Case, A.S.2    Hoff, J.T.3
  • 12
    • 0041381133 scopus 로고    scopus 로고
    • Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy
    • Lujan AE, Mundt AJ, Yamada SD, Rotmensch J, Roeske JC. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57(2):516-21.
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , Issue.2 , pp. 516-521
    • Lujan, A.E.1    Mundt, A.J.2    Yamada, S.D.3    Rotmensch, J.4    Roeske, J.C.5
  • 13
    • 24944455909 scopus 로고    scopus 로고
    • Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome
    • Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys. 2005;63(2):354-61.
    • (2005) Int J Radiat Oncol Biol Phys , vol.63 , Issue.2 , pp. 354-361
    • Milano, M.T.1    Jani, A.B.2    Farrey, K.J.3    Rash, C.4    Heimann, R.5    Chmura, S.J.6
  • 14
    • 47149090225 scopus 로고    scopus 로고
    • Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer
    • Mell LK, Tiryaki H, Ahn KH, Mundt AJ, Roeske JC, Aydogan B. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71(5):1504-10.
    • (2008) Int J Radiat Oncol Biol Phys , vol.71 , Issue.5 , pp. 1504-1510
    • Mell, L.K.1    Tiryaki, H.2    Ahn, K.H.3    Mundt, A.J.4    Roeske, J.C.5    Aydogan, B.6
  • 15
    • 84876030531 scopus 로고    scopus 로고
    • Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.
    • Klopp AH, Moughan J, Portelance L, et al. Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. Int J Radiat Oncol Biol Phys. 2013;86(1):83-90.
    • (2013) Int J Radiat Oncol Biol Phys , vol.418 , Issue.1 , pp. 83-90
    • Klopp, A.H.1    Moughan, J.2    Portelance, L.3
  • 16
    • 33751186686 scopus 로고    scopus 로고
    • Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy
    • Mell LK, Kochanski JD, Roeske JC, et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66(5):1356-65.
    • (2006) Int J Radiat Oncol Biol Phys , vol.66 , Issue.5 , pp. 1356-1365
    • Mell, L.K.1    Kochanski, J.D.2    Roeske, J.C.3
  • 17
    • 40949099019 scopus 로고    scopus 로고
    • Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy
    • Mell LK, Schomas DA, Salama JK, et al. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70(5):1431-37.
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , Issue.5 , pp. 1431-1437
    • Mell, L.K.1    Schomas, D.A.2    Salama, J.K.3
  • 18
    • 35148853675 scopus 로고    scopus 로고
    • 18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment
    • Agool A, Schot BW, Jager PL, Vellenga E. 18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment. J Nucl Med. 2006;47(10):1592-98.
    • (2006) J Nucl Med , vol.47 , Issue.10 , pp. 1592-1598
    • Agool, A.1    Schot, B.W.2    Jager, P.L.3    Vellenga, E.4
  • 19
    • 79954588577 scopus 로고    scopus 로고
    • A methodology for incorporating functional bone marrow sparing in IMRT planning for pelvic radiation therapy
    • McGuire SM, Menda Y, Ponto LL, Gross B, Juweid M, Bayouth JE. A methodology for incorporating functional bone marrow sparing in IMRT planning for pelvic radiation therapy. Radiother Oncol. 2011;99(1):49-54.
    • (2011) Radiother Oncol , vol.99 , Issue.1 , pp. 49-54
    • McGuire, S.M.1    Menda, Y.2    Ponto, L.L.3    Gross, B.4    Juweid, M.5    Bayouth, J.E.6
  • 20
    • 0036732034 scopus 로고    scopus 로고
    • Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells
    • Rasey JS, Grierson JR, Wiens LW, Kolb PD, Schwartz JL. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med. 2002;43(9):1210-17.
    • (2002) J Nucl Med , vol.43 , Issue.9 , pp. 1210-1217
    • Rasey, J.S.1    Grierson, J.R.2    Wiens, L.W.3    Kolb, P.D.4    Schwartz, J.L.5
  • 22
    • 77952491627 scopus 로고    scopus 로고
    • Investigation of the pharmacokinetics of 3'-deoxy-3'-[18F]fluorothymidine uptake in the bone marrow before and early after initiation of chemoradiation therapy in head and neck cancer
    • Menda Y, Ponto LL, Dornfeld KJ, et al. Investigation of the pharmacokinetics of 3'-deoxy-3'-[18F]fluorothymidine uptake in the bone marrow before and early after initiation of chemoradiation therapy in head and neck cancer. Nucl Med Biol. 2010;37(4):433-38.
    • (2010) Nucl Med Biol , vol.37 , Issue.4 , pp. 433-438
    • Menda, Y.1    Ponto, L.L.2    Dornfeld, K.J.3
  • 23
    • 0033925065 scopus 로고    scopus 로고
    • Simplified labeling approach for synthesizing 3′-Deoxy-3′-[18F]fluorothymidine ([18F]FLT)
    • Machulla HJ, Blocher A, Kuntzsch M, Piert M, Wei R, Grierson JR. Simplified labeling approach for synthesizing 3′-Deoxy-3′-[18F]fluorothymidine ([18F]FLT). J Radioanal Nucl Chem. 2000;243(3):843-46.
    • (2000) J Radioanal Nucl Chem , vol.243 , Issue.3 , pp. 843-846
    • Machulla, H.J.1    Blocher, A.2    Kuntzsch, M.3    Piert, M.4    Wei, R.5    Grierson, J.R.6
  • 24
    • 27144497801 scopus 로고    scopus 로고
    • Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies
    • Roeske JC, Lujan A, Reba RC, Penney BC, Diane Yamada S, Mundt AJ. Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies. Radiother Oncol. 2005;77(1):11-17.
    • (2005) Radiother Oncol , vol.77 , Issue.1 , pp. 11-17
    • Roeske, J.C.1    Lujan, A.2    Reba, R.C.3    Penney, B.C.4    Diane Yamada, S.5    Mundt, A.J.6
  • 25
    • 84872170621 scopus 로고    scopus 로고
    • Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies
    • Liang Y, Bydder M, Yashar CM, et al. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys. 2013;85(2):406-14.
    • (2013) Int J Radiat Oncol Biol Phys , vol.85 , Issue.2 , pp. 406-414
    • Liang, Y.1    Bydder, M.2    Yashar, C.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.